Patents by Inventor Venkat R. Goskonda

Venkat R. Goskonda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable cannabinoid formulations
    Patent number: 11911361
    Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.
    Type: Grant
    Filed: September 22, 2017
    Date of Patent: February 27, 2024
    Assignee: RADIUS PHARMACEUTICALS, INC.
    Inventors: Kiran Kumar Vangara, Huaguang Li, Ningxin Yan, Hung Q. Nguyen, Venkat R. Goskonda
  • Methods of stabilizing epinephrine
    Patent number: 11744811
    Abstract: The present invention is directed to methods of stabilizing a pharmaceutical composition comprising epinephrine containing the steps filling a container, capping the container, assembling the container and placing the assembled capped container (assembled device) in a secondary packaging system.
    Type: Grant
    Filed: June 30, 2021
    Date of Patent: September 5, 2023
    Assignee: Hikma Pharmaceuticals USA Inc.
    Inventors: Eshwaran Narayanan, Rajesh Wakaskar, Chandeshwari Chilampalli, Thrimoorthy Potta, Venkat R. Goskonda
  • LIQUID NALOXONE SPRAY
    Publication number: 20230181457
    Abstract: The invention provides stable liquid formulations containing naloxone, a pharmaceutically acceptable salt or a derivative thereof. The invention further provides methods for treating opioid overdose, opioid dependence, and congenital insensitivity to pain with anhidrosis by administering the liquid formulations of the present invention intranasally to a patient in need thereof. Further, the invention provides a method of treating opioid dependence, opioid overdose, and congenital insensitivity to pain with anhidrosis by administering intranasally the naloxone formulations of the present invention.
    Type: Application
    Filed: February 14, 2023
    Publication date: June 15, 2023
    Inventors: Kiran Amancha, Chandeshwari Chilampalli, Thrimoorthy Potta, Ningxin Yan, Venkat R. Goskonda
  • Liquid naloxone spray
    Patent number: 11628139
    Abstract: The invention provides stable liquid formulations containing naloxone, a pharmaceutically acceptable salt or a derivative thereof. The invention further provides methods for treating opioid overdose, opioid dependence, and congenital insensitivity to pain with anhidrosis by administering the liquid formulations of the present invention intranasally to a patient in need thereof. Further, the invention provides a method of treating opioid dependence, opioid overdose, and congenital insensitivity to pain with anhidrosis by administering intranasally the naloxone formulations of the present invention.
    Type: Grant
    Filed: March 11, 2021
    Date of Patent: April 18, 2023
    Assignee: Hikma Pharmaceuticals USA Inc.
    Inventors: Kiran Amancha, Chandeshwari Chilampalli, Thrimoorthy Potta, Ningxin Yan, Venkat R. Goskonda
  • Liquid naloxone spray
    Patent number: 11617713
    Abstract: The invention provides stable liquid formulations containing naloxone, a pharmaceutically acceptable salt or a derivative thereof. The invention further provides methods for treating opioid overdose, opioid dependence, and congenital insensitivity to pain with anhidrosis by administering the liquid formulations of the present invention intranasally to a patient in need thereof. Further, the invention provides a method of treating opioid dependence, opioid overdose, and congenital insensitivity to pain with anhidrosis by administering intranasally the naloxone formulations of the present invention.
    Type: Grant
    Filed: March 11, 2021
    Date of Patent: April 4, 2023
    Assignee: Hikma Pharmaceuticals USA Inc.
    Inventors: Kiran Amancha, Chandeshwari Chilampalli, Thrimoorthy Potta, Ningxin Yan, Venkat R. Goskonda
  • LIQUID NALOXONE SPRAY
    Publication number: 20230008410
    Abstract: The invention provides stable liquid formulations containing naloxone, a pharmaceutically acceptable salt or a derivative thereof. The invention further provides methods for treating opioid overdose, opioid dependence, and congenital insensitivity to pain with anhidrosis by administering the liquid formulations of the present invention intranasally to a patient in need thereof. Further, the invention provides a method of treating opioid dependence, opioid overdose, and congenital insensitivity to pain with anhidrosis by administering intranasally the naloxone formulations of the present invention.
    Type: Application
    Filed: August 25, 2021
    Publication date: January 12, 2023
    Inventors: Kiran Amancha, Chandeshwari Chilampalli, Thrimoorthy Potta, Ningxin Yan, Venkat R. Goskonda
  • STABLE CANNABINOID FORMULATIONS
    Publication number: 20220280446
    Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.
    Type: Application
    Filed: February 18, 2022
    Publication date: September 8, 2022
    Applicant: RADIUS PHARMACEUTICALS, INC.
    Inventors: Kiran Kumar Vangara, Huaguang Li, Ningxin Yan, Hung Q. Nguyen, Venkat R. Goskonda
  • STABLE CANNABINOID FORMULATIONS
    Publication number: 20220184215
    Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.
    Type: Application
    Filed: December 22, 2021
    Publication date: June 16, 2022
    Applicant: RADIUS PHARMACEUTICALS, INC.
    Inventors: Kiran Kumar VANGARA, Huaguang LI, Ningxin YAN, Hung Q. Nguyen, Venkat R. GOSKONDA
  • Oral Cannabinoid Formulations
    Publication number: 20220160626
    Abstract: Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.
    Type: Application
    Filed: February 14, 2022
    Publication date: May 26, 2022
    Applicant: Benuvia Therapeutics, LLC
    Inventors: VENKAT R GOSKONDA, Ashok Chavan, Amit Kokate, Howard Gil
  • Stable cannabinoid formulations
    Patent number: 11331279
    Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: May 17, 2022
    Assignee: RADIUS PHARMACEUTICALS, INC.
    Inventors: Kiran Kumar Vangara, Huaguang Li, Ningxin Yan, Hung Q. Nguyen, Venkat R. Goskonda
  • TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20220133626
    Abstract: The invention is directed to a topical composition comprising one or more topical active ingredients, one or more nonionic surfactants, one or more viscosity enhancers, polyethylene glycol and menthol. The invention is further directed to a method of reducing or eliminating pain comprising applying a composition of the present invention to a subject in need thereof.
    Type: Application
    Filed: January 19, 2022
    Publication date: May 5, 2022
    Inventors: Gerald Horn, Venkat R. Goskonda
  • TOPICAL ANALGESIC COMPOSITIONS AND METHODS OF USE
    Publication number: 20220133658
    Abstract: The present invention is directed to topical skin composition comprising one or more active ingredients and one or more permeation enhancers. The present invention is further directed to a method of reducing or eliminating pain.
    Type: Application
    Filed: January 19, 2022
    Publication date: May 5, 2022
    Inventors: Venkat R. Goskonda, Ravi Nallakrishnan
  • STABLE CANNABINOID FORMULATIONS
    Publication number: 20220125932
    Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.
    Type: Application
    Filed: November 5, 2021
    Publication date: April 28, 2022
    Applicant: RADIUS PHARMACEUTICALS INC.
    Inventors: Kiran Kumar VANGARA, Huaguang Li, Ningxin Yan, Hung Q. Nguyen, Venkat R. Goskonda
  • TOPICAL COMPOSITIONS AND METHODS OF USE
    Publication number: 20220079873
    Abstract: The present invention is directed to a topical composition comprising one or more active ingredients and one or more permeation enhancers. The present invention is further directed to a method of reducing or eliminating one or more conditions selected from the group consisting of pain, hemorrhoids, acne, wrinkles and scars.
    Type: Application
    Filed: September 8, 2021
    Publication date: March 17, 2022
    Inventors: Venkat R. Goskonda, Ravi Nallakrishnan
  • STABLE CANNABINOID FORMULATIONS
    Publication number: 20220054450
    Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.
    Type: Application
    Filed: November 5, 2021
    Publication date: February 24, 2022
    Applicant: RADIUS PHARMACEUTICALS, INC.
    Inventors: Kiran Kumar Vangara, Huaguang Li, Ningxin Yan, Hung Q. Nguyen, Venkat R. Goskonda
  • Oral cannabinoid formulations
    Patent number: 11253472
    Abstract: Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: February 22, 2022
    Assignee: Benuvia Therapeutics LLC
    Inventors: Venkat R. Goskonda, Ashok Chavan, Amit Kokate, Howard Gill
  • Stable cannabinoid formulations
    Patent number: 11224660
    Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: January 18, 2022
    Assignee: RADIUS PHARMACEUTICALS, INC.
    Inventors: Kiran Kumar Vangara, Huaguang Li, Ningxin Yan, Hung Q. Nguyen, Venkat R. Goskonda
  • LIQUID NALOXONE SPRAY
    Publication number: 20210353533
    Abstract: The invention provides stable liquid formulations containing naloxone, a pharmaceutically acceptable salt or a derivative thereof. The invention further provides methods for treating opioid overdose, opioid dependence, and congenital insensitivity to pain with anhidrosis by administering the liquid formulations of the present invention intranasally to a patient in need thereof. Further, the invention provides a method of treating opioid dependence, opioid overdose, and congenital insensitivity to pain with anhidrosis by administering intranasally the naloxone formulations of the present invention.
    Type: Application
    Filed: March 11, 2021
    Publication date: November 18, 2021
    Inventors: Kiran Amancha, Chandeshwari Chilampalli, Thrimoorthy Potta, Ningxin Yan, Venkat R. Goskonda
  • METHODS OF STABILIZING EPINEPHRINE
    Publication number: 20210338604
    Abstract: The present invention is directed to methods of stabilizing a pharmaceutical composition comprising epinephrine containing the steps filling a container, capping the container, assembling the container and placing the assembled capped container (assembled device) in a secondary packaging system.
    Type: Application
    Filed: June 30, 2021
    Publication date: November 4, 2021
    Inventors: Eshwaran Narayanan, Rajesh Wakaskar, Chandeshwari Chilampalli, Thrimoorthy Potta, Venkat R. Goskonda
  • STABLE CANNABINOID FORMULATIONS
    Publication number: 20210330797
    Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.
    Type: Application
    Filed: July 6, 2021
    Publication date: October 28, 2021
    Applicant: RADIUS PHARMACEUTICALS, INC.
    Inventors: Kiran Kumar Vangara, Huaguang Li, Ningxin Yan, Hung Q. Nguyen, Venkat R. Goskonda